LINC02789

Across TCGA pan-cancer cohorts, LINC02789 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC02789 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02789 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02789 expression acts as an unfavorable survival marker, although some lineages such as BRCA and THYM show a favorable association.

STAD, KICH, and HNSC are the cancer types where LINC02789 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.345	0.741	<.001	78	view →
KICH	OS	Tertile	All	0.161	0.881	<.001	72	view →
HNSC	DFS	Tertile	II,III,IV	0.557	0.693	.029	45	view →
BLCA	DFS	Tertile	All	0.206	0.513	.024	36	view →
LIHC	DFS	Tertile	All	0.057	0.556	<.001	33	view →
OV	OS	Tertile	IV	0.551	0.788	.020	30	view →
BRCA	DFS	Tertile	All	0.900	0.503	.017	30	view →
THCA	DFS	Tertile	II,III,IV	0.121	0.687	.009	27	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	18	view →
SARC	OS	Tertile	All	0.527	0.798	.002	15	view →
THYM	DFS	Tertile	All	0.906	0.594	.024	9	view →
KIRC	DFS	Tertile	All	0.387	0.643	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC02789–STAD (DFS)

Open the STAD breakdown →